Does Dr. KELLEY BANAGAN have financial conflicts of interest?

Dr. KELLEY BANAGAN (MD) has received a total of $185 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $185 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. KELLEY BANAGAN?

According to CMS Open Payments data, Dr. KELLEY BANAGAN received funding from DEPUY SYNTHES SALES ($97), PACIRA PHARMACEUTICALS INCORPORATED ($76), and SI-BONE ($11).

Does Dr. KELLEY BANAGAN receive research grants or speaking fees?

Dr. KELLEY BANAGAN has received $185 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. KELLEY BANAGAN

MDReal-Time Hydrated

Specialty: Orthopaedic Surgery, Orthopaedic Surgery of the Spine

Practice Location: CHARLESTON, SC 29425

NPI Number: 1851435408

LIFETIME INDUSTRY VALUE

$185

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BANAGAN is a verified Orthopaedic Surgery, Orthopaedic Surgery of the Spine practitioner based in CHARLESTON, SC.

Between 2021 and 2024, Dr. BANAGAN had an overall industry promotional and research financial footprint of $185 as recorded in the federal CMS Open Payments database.

$185 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BANAGAN's primary funding source is DEPUY SYNTHES SALES, which accounts for $97 (representing 52.5% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

DEPUY SYNTHES SALES

Rank 1

$97

52.5%

PACIRA PHARMACEUTICALS INCORPORATED

Rank 2

$76

41.3%

SI-BONE

Rank 3

$11

6.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.